| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T107 |
0-5 |
Sentence |
denotes |
Notes |
| T108 |
6-22 |
Sentence |
denotes |
Acknowledgments. |
| T109 |
23-330 |
Sentence |
denotes |
The contributions of the entire Global Pathogen Safety team, most notably Simone Knotzer, Melanie Graf, Jasmin de Silva, Julius Segui (neutralization assays), Veronika Sulzer, Sabrina Brandtner (cell culture), as well as Eva Ha and Alexandra Schlapschy-Danzinger (virus culture) are gratefully acknowledged. |
| T110 |
331-415 |
Sentence |
denotes |
The team of Plasma Analytics, Takeda, Vienna prepared the human plasma pool samples. |
| T111 |
416-615 |
Sentence |
denotes |
SARS-CoV-2 was sourced via EVAg (supported by the European Community) and kindly provided by Christian Drosten and Victor Corman (Charité Universitätsmedizin, Institute of Virology, Berlin, Germany). |
| T112 |
616-634 |
Sentence |
denotes |
Financial support. |
| T113 |
635-732 |
Sentence |
denotes |
This work was supported by Baxter AG, now part of the Takeda group of companies, Vienna, Austria. |
| T114 |
733-765 |
Sentence |
denotes |
Potential conflicts of interest. |
| T115 |
766-861 |
Sentence |
denotes |
Authors are employees of Baxter AG, now part of the Takeda group of companies, Vienna, Austria. |
| T116 |
862-864 |
Sentence |
denotes |
M. |
| T117 |
865-871 |
Sentence |
denotes |
K., C. |
| T118 |
872-878 |
Sentence |
denotes |
A., M. |
| T119 |
879-881 |
Sentence |
denotes |
R. |
| T120 |
882-892 |
Sentence |
denotes |
F., and T. |
| T121 |
893-895 |
Sentence |
denotes |
R. |
| T122 |
896-926 |
Sentence |
denotes |
K. have Takeda stock interest. |
| T123 |
927-1019 |
Sentence |
denotes |
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. |
| T124 |
1020-1118 |
Sentence |
denotes |
Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. |
